1. Berrino F.  The EUROCARE Study: strengths, limitations and perspectives of  population-based, comparative survival studies (full text PDF). Ann Oncol. 2003;14 Suppl 5:V9-V13.

2. Micheli A, Baili P, Quinn M, Mugno E, Capocaccia R, Grosclaude P; The EUROCARE Working Group. Life expectancy and cancer survival in the EUROCARE-3 cancer registry areas (full text PDF). Ann Oncol. 2003;14 Suppl 5:V28-V40.

3. Micheli A, Coebergh JW, Mugno E, Massimiliani E, Sant M, Oberaigner W, Holub J, Storm HH, Forman D, Quinn M, Aareleid T, Sankila R, Hakulinen T, Faivre J, Ziegler H, Tryggvadottir L, Zanetti R, Dalmas M, Visser O, Langmark F, Bielska-Lasota M, Wronkowski Z, Pinheiro PS, Brewster DH, Plesko I, Pompe-Kirn V, Martinez-Garcia C, Barlow L, Moller T, Lutz JM, Andre M, Steward JA. European health systems and cancer care (full text PDF). Ann Oncol. 2003;14 Suppl 5:V41-V60.

4. Sant M, Aareleid T, Berrino F, Bielska Lasota M, Carli PM, Faivre J, Grosclaude P, Hedelin G, Matsuda T, Moller H, Moller T, Verdecchia A, Capocaccia R, Gatta G, Micheli A, Santaquilani M, Roazzi P, Lisi D; The EUROCARE Working Group. EUROCARE-3: survival of cancer patients diagnosed 1990-94-results and commentary (full text PDF). Ann Oncol. 2003;14 Suppl 5:V61-V118.

5. Gatta G, Corazziari I, Magnani C, Peris-Bonet R, Roazzi P, Stiller C; The EUROCARE Working Group. Childhood cancer survival in Europe (full text PDF). Ann Oncol. 2003;14 Suppl 5:V119-V127. 

6. Coleman MP, Gatta G, Verdecchia A, Esteve J, Sant M, Storm H, Allemani C, Ciccolallo L, Santaquilani M, Berrino F; The EUROCARE Working Group. EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century (full text PDF). Ann Oncol. 2003;14 Suppl 5:V128-V149.

7. Sant M, Allemani C, Capocaccia R, Hakulinen T, Aareleid T, Coebergh JW, Coleman MP, Grosclaude P, Martinez C, Bell J, Youngson J, Berrino F; EUROCARE Working Group. Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer. 2003 Sep 1;106(3):416-22.

8. Marinaccio A, Nesti M; Regional Operational Centers. Analysis of survival of mesothelioma cases in the Italian register (ReNaM). Eur J Cancer. 2003 Jun;39(9):1290-5.

9. Conti S, Farchi G, Masocco M, Minelli G, Toccaceli V, Vichi M. Gender differentials in life expectancy in Italy. Eur J Epidemiol. 2003;18(2):107-12.

10. Quaglia A, Vercelli M, Puppo A, Casella C, Artioli E, Crocetti E, Falcini F, Ramazzotti V, Tagliabue G Prostate Working Group. Prostate cancer in Italy before and during the "PSA era": survival trend and prognostic determinants. Eur J Cancer Prev. 2003 Apr;12(2):145-52.

11. Crocetti E, Bernini G, Tamburini A, Miccinesi G, Paci E. Incidence and survival cancer trends in children and adolescents in the Provinces of Florence and Prato (Central Italy), 1985-1997. Tumori. 2002 Nov-Dec;88(6):461-6.

12. Balzi D, Carli P, Giannotti B, Paci E, Buiatti E. Cutaneous melanoma in the Florentine area, Italy: incidence, survival and mortality between 1985 and 1994. Eur J Cancer Prev. 2003 Feb;12(1):43-8.

13. Pasquali C, Sperti C, Filipponi C, Pedrazzoli S. Epidemiology of pancreatic cancer in Northeastern Italy: incidence, resectability rate, hospital stay, costs and survival. (1990-1992). Dig Liver Dis. 2002 Oct;34(10):723-31.

14. Gatta G, Capocaccia R, Coleman MP, Ries LA, Berrino F. Childhood cancer survival in Europe and the United States. Cancer. 2002 Oct 15;95(8):1767-72.

15. Magnani C, Viscomi S, Dalmasso P, Ivaldi C, Mirabelli D, Terracini B. Survival after pleural malignant mesothelioma: a population-based study in Italy. Tumori. 2002 Jul-Aug;88(4):266-9.

16. Rosso S, Casella C, Crocetti E, Ferretti S, Guzzinati S. Sopravvivenza dei casi di tumore in Italia negli anni novanta: i dati dei Registri Tumori. Epidemiologia e Prevenzione 2001: 25 (3) suppl:1-375.

17. Berrino F, Capocaccia R, Estève J, Gatta G, Hakulinen T, Micheli A, Sant M, Verdecchia A (eds). Survival of cancer patients in Europe: The EUROCARE study II. IARC Scientific Publications 1999, 151. Lyon, IARC.

18. Verdecchia A, De Angelis R, Capocaccia R, Sant M, Micheli A, Gatta G, Berrino F. The cure of colon cancer: results from Eurocare study. Int J Cancer. 1998 Jul 29;77(3):322-9.

19. Micheli A, Gatta G, Verdecchia A. Studying survival of cancer patients in different populations: its potential and role. Tumori 1997 Jan-Feb;83(1):3-8.

20. Verdecchia A, Micheli A, Gatta G, et al, editors. Survival of cancer patients in Italy: the ITACARE Study. Tumori 1997, 83, 1-507.

21. Berrino F, Micheli A, Sant M, Capocaccia R. Interpreting survival differences and trends. Tumori 1997 Jan-Feb;83(1):9-16.

22. Gatta G, Sant M, Micheli A, Capocaccia R, Verdecchia A, Barchielli A, Gafa L, Ramazzotti V, Berrino F. Survival for digestive system tumors: Italian population-based data and international comparisons. Ann Ist Super Sanità. 1996;32(4):513-25.

23. Ponz De Leon M, Micheli A, Gatta G, Capocaccia R, Sant M, Gafa L, Conti EM, Roncucci L, Berrino F. Survival for tumors of the colon and the rectum in Italy. Ann Ist Super Sanità 1996;32(4):527-36.

24. Roncucci L, Fante R, Losi L, Di Gregorio C, Micheli A, Benatti P, Madenis N, Ganazzi D, Cassinadri MT, Lauriola P, Ponz de Leon M. Survival for colon and rectal cancer in a population-based cancer registry. Eur J Cancer 1996 Feb;32A(2):295-302.

25. Berrino F, Sant M, Verdecchia A, Capocaccia R, Hakulinen T, Estève J (eds). Survival of cancer patients in Europe.The EUROCARE study. IARC Scientific Publications No 132. Lyon IARC 1995.

26. Micheli A, Capocaccia R. General mortality and its effect on survival estimates. IARC Sci Publ 1995;(132):38-46.
    

Treatment delay

1. Reed AD, Williams RJ, Wall PA, Hasselback P. Waiting time for breast cancer treatment in Alberta. Can J Public Health. 2004 Sep-Oct;95(5):341-5.

2. Benk V, Joseph L, Fortin P, Zhang G, Belisle P, Levinton C, Ho V, Freeman CR. Effect of delay in initiating radiotherapy for patients with early stage breast cancer. Clin Oncol (R Coll Radiol). 2004 Feb;16(1):6-11.

3. Nam RK, Jewett MA, Krahn MD, Robinette MA, Tsihlias J, Toi A, Ho M, Evans A, Sweet J, Trachtenberg J. Delay in surgical therapy for clinically localized prostate cancer and biochemical recurrence after radical prostatectomy. Can J Urol. 2003 Jun;10(3):1891-8.

4. Waaijer A, Terhaard CH, Dehnad H, Hordijk GJ, van Leeuwen MS, Raaymakers CP, Lagendijk JJ. Waiting times for radiotherapy: consequences of volume increase for the TCP in oropharyngeal carcinoma. Radiother Oncol. 2003 Mar;66(3):271-6.

5. Coles CE, Burgess L, Tan LT. An audit of delays before and during radical radiotherapy for cervical cancer--effect on tumour cure probability. Clin Oncol (R Coll Radiol). 2003 Apr;15(2):47-54.

6. Seel M, Foroudi F. Waiting for radiation therapy: does it matter? Australas Radiol. 2002 Sep;46(3):275-9.

7. Jensen AR, Mainz J, Overgaard J. Impact of delay on diagnosis and treatment of primary lung cancer. Acta Oncol. 2002;41(2):147-52.

8. Jones TM, Hargrove O, Lancaster J, Fenton J, Shenoy A, Roland NJ. Waiting times during the management of head and neck tumours. J Laryngol Otol. 2002 Apr;116(4):275-9.

9. Olivotto IA, Bancej C, Goel V, Snider J, McAuley RG, Irvine B, Kan L, Mirsky D, Sabine MJ, McGilly R, Caines JS. Waiting times from abnormal breast screen to diagnosis in 7 Canadian provinces. CMAJ. 2001 Aug 7;165(3):277-83.

10. O'Rourke N, Edwards R. Lung cancer treatment waiting times and tumour growth. Clin Oncol (R Coll Radiol). 2000;12(3):141-4.

11. Mackillop WJ, Fu H, Quirt CF, Dixon P, Brundage M, Zhou Y. Waiting for radiotherapy in Ontario. Int J Radiat Oncol Biol Phys. 1994 Aug 30;30(1):221-8.

12. Colbert K. The longer the delay, the greater the anxiety. Delay in treatment for breast cancer. Prof Nurse. 1994 May;9(8):517-20.

13. Iatrakis G, Kourounis G, Georgopoulos N, Karachotzitis J. Treatment delay and pathology results in women with low-grade squamous intraepithelial lesions. A preliminary study.Eur J Gynaecol Oncol. 2004;25(3):376-8.

14. Zagars GK, Cormier JN, Hunt KK, Feig BW, Patel SR, Pisters PW. Interval between surgery and radiotherapy: effect on local control of soft tissue sarcoma. Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1461-7.

15. Myrdal G, Lambe M, Hillerdal G, Lamberg K, Agustsson T, Stahle E. Effect of delays on prognosis in patients with non-small cell lung cancer. Thorax. 2004 Jan;59(1):45-9.

16. Look M, Tan YY, Vijayan A, Teh CH, Low CH. Management delays for early gastric cancer in a country without mass screening. Hepatogastroenterology. 2003 May-Jun;50(51):873-6.

17. Langenbach MR, Schmidt J, Neumann J, Zirngibl H. Delay in treatment of colorectal cancer: multifactorial problem. World J Surg. 2003 Mar;27(3):304-8. Epub 2003 Feb 27.

18. Crawford SC, Davis JA, Siddiqui NA, de Caestecker L, Gillis CR, Hole D, Penney G. The waiting time paradox: population based retrospective study of treatment delay and survival of women with endometrial cancer in Scotland. BMJ. 2002 Jul 27;325(7357):196.

19. Fortin A, Bairati I, Albert M, Moore L, Allard J, Couture C. Effect of treatment delay on outcome of patients with early-stage head-and-neck carcinoma receiving radical radiotherapy. Int J Radiat Oncol Biol Phys. 2002 Mar 15;52(4):929-36.

20. Bozcuk H, Martin C. Does treatment delay affect survival in non-small cell lung cancer? A retrospective analysis from a single UK centre. Lung Cancer. 2001 Nov;34(2):243-52.

21. Menczer J, Krissi H, Chetrit A, Gaynor J, Lerner L, Ben-Baruch G, Modan B. The effect of diagnosis and treatment delay on prognostic factors and survival in endometrial carcinoma. Am J Obstet Gynecol. 1995 Sep;173(3 Pt 1):774-8. Erratum in: Am J Obstet Gynecol 1996 Dec;175(6):1678. Gaylor J [corrected to Gaynor J].